
The survey asked about patient cannabis use, openness to discussing cannabis as part of treatment plans, and perspectives on substance use of physicians.
The survey asked about patient cannabis use, openness to discussing cannabis as part of treatment plans, and perspectives on substance use of physicians.
This webinar covered how cannabis for this neurodegenerative disease could provide better symptom relief and improve quality of life better than conventional treatments.
This webinar discussed recent research on medical cannabis for conditions such as alcohol use disorder and chronic pain, directed for attendees of all backgrounds.
In a special Roundtable discussion, the Veterans Action Council (VAC) invited Dr. Ethan Russo to discuss this syndrome, its growing prevalence, research, potential dangers, and possible solutions.
The December webinar from Healer featured several studies on various conditions treated with medical cannabis.
This month’s webinar covered research on cannabis studied as a treatment for rheumatic disorders, menstrual symptoms, eczema, and more.
Overall, the survey revealed that people with chronic pain supported policies expanding medical cannabis access more than physicians.
Panelists discussed the impacts of cannabis as a schedule 3 substance on research, legislation, patients, and more.
This month’s Healer webinar provided a deep dive into several studies on cannabis for various conditions.
Americans for Safe Access, a medical cannabis patient advocacy organization, held a briefing on the final day of the comment period for the proposed rulemaking on cannabis.
Let’s take a look at the most recent webinars on cannabis research and medicine to catch up on industry trends and innovations.
This webinar from MM411 explored the far-ranging studies of Dr. Raphael Mechoulam and Dr. Ethan Russo on the science and medicine of cannabis and other plants.
The final installment of this webinar series discussed recommendations for new policies integrating cannabis into harm reduction efforts.
In the second installment in this webinar series, Dr. Marion McNabb and Dr. Peter Grinspoon discuss implementation of cannabis as a harm reduction agent from a clinical perspective.
In the first installment of a three-part webinar series, Dr. Marion McNabb and Dr. Peter Grinspoon share their insights on cannabis as a harm reduction option.
Let’s meet Cannabis Science Conference Fall speaker Dr. Travis Poonai, a pharmacist with a specialty in medical cannabis.
Based on his 13 years of clinical experience, Dr. Dustin Sulak explains strategies in effectively treating chronic pain while reducing or eliminating adverse effects.
Dr. Dustin Sulak discusses his clinical experience with cannabis as a treatment for anxiety and PTSD as well as some of the clinical evidence surrounding the endocannabinoid system.
What do we know about the safety and efficacy of THC in children? Here, Dr. Sulak addresses that question and more.
In this video interview, Dr. Dustin Sulak of Healer.com and Integr8 Health shares his experience with older patients and women who are interested in medical cannabis or psychedelics.
In this video interview, Dr. Dustin Sulak of Healer.com and Integr8 Health shares what he hopes to see happen in the future for patients interested in medical cannabis and psychedelics.
In this video interview, Dr. Dustin Sulak of Healer.com and Integr8 Health shares the most surprising results and quality of treatment response he sees when treating his patients with medical cannabis and psychedelics.
In this video interview, Dr. Dustin Sulak of Healer.com and Integr8 Health shares the biggest challenge he encounters when educating other healthcare professionals on medical cannabis, both in the past and today.
Dr. Dustin Sulak of Healer.com and Integr8 Health shares some insights from two talks he gave at Cannabis Science Conference East 2022.
Here, Dr. Dustin Sulak shares how stress is a major factor in the development and progression of autoimmune diseases and how cannabis can be a great tool in alleviating symptoms.